CTS B-27 Supplement XenoFree Minus Insulin is based on the classic B-27 Supplement formulation and contains no animal-derived components at the primary component level. The absence of insulin makes this formulation ideal for the growth of hippocampal and other CNS neurons in applications where the presence of insulin causes interference or in the derivation of cardiomyocytes and mesodermal cells from stem cells. CTS B-27 Supplement XenoFree Minus Insulin reduces the burden in qualifying reagents when transitioning from the research bench to the clinic.
CTS quality Gibco CTS products are manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing sites are ISO 13485– and ISO 9001–certified.
Formulated xeno-free The preparation contains no animal-derived components at the primary component level.
Accompanied by documentation to support your regulatory filing Specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available.